Surgical outcomes of hepatocellular carcinoma with extrahepatic bile duct tumor thrombus: a multicenter study
Frontiers in Oncology · 04.12.2023 · 13
DOI: 10.3389/fonc.2023.1291479 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 04.12.2023. Verfasst von Li-Ming Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Shengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The long-term prognosis after surgery of patients with hepatocellular carcinoma (HCC) and extrahepatic bile duct tumor thrombus (Ex-BDTT) remains unknown. We aimed to identify the surgical outcomes of patients with HCC and Ex-BDTT.
Methods
A total of 138 patients with Ex-BDTT who underwent hepatectomy with preservation of the extrahepatic bile duct from five large hospitals in China between January 2009 and December 2017 were included. The Cox proportional hazards model was used to analyze overall survival (OS) and recurrence-free survival (RFS).
Results
With a median follow-up of 60 months (range, 1–127.8 months), the median OS and RFS of the patients were 28.6 and 8.9 months, respectively. The 1-, 3-, and 5-year OS rates of HCC patients with Ex-BDTT were 71.7%, 41.2%, and 33.5%, respectively, and the corresponding RFS rates were 43.5%, 21.7%, and 20.0%, respectively. Multivariate analysis identified that major hepatectomy, R0 resection, and major vascular invasion were independent prognostic factors for OS and RFS. In addition, preoperative serum total bilirubin ≥ 4.2 mg/dL was an independent prognostic factor for RFS.
Conclusion
Major hepatectomy with preservation of the extrahepatic bile duct can provide favorable long-term survival for HCC patients with Ex-BDTT.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China.
- Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Fuzhou, Fujian, China.
- Department of General Surgery, Fujian Provincial Hospital South Branch, Fuzhou, Fujian, China.
- Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.
Zitieren
APA
Huang, L. M., Zeng, Z. X., Wu, J. Y., Li, Y. N., Wang, J. X., Fu, Y. K., Wu, J. Y., Wei, S. M., Lv, J. H., Chen, W. Z., Huang, R. F., Cheng, S. Q., & Yan, M. L. (2023). Surgical outcomes of hepatocellular carcinoma with extrahepatic bile duct tumor thrombus: a multicenter study. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1291479
Vancouver
Huang LM, Zeng ZX, Wu JY, Li YN, Wang JX, Fu YK, et al. Surgical outcomes of hepatocellular carcinoma with extrahepatic bile duct tumor thrombus: a multicenter study. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1291479
BibTeX
@article{Huang2023,
author = {Huang, Li-Ming and Zeng, Zhen-Xin and Wu, Jun-Yi and Li, Yi-Nan and Wang, Jin-Xiu and Fu, Yang-Kai and Wu, Jia-Yi and Wei, Shao-Ming and Lv, Jia-Hui and Chen, Wei-Zhao and Huang, Rong-Fa and Cheng, Shu-Qun and Yan, Mao-Lin},
title = {Surgical outcomes of hepatocellular carcinoma with extrahepatic bile duct tumor thrombus: a multicenter study},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1291479}
}
EUVIMED